BioHarvest Sciences Statistics

Total Valuation

BioHarvest Sciences has a market cap or net worth of CAD 130.82 million. The enterprise value is 137.97 million.

Market Cap	130.82M
Enterprise Value	137.97M

Important Dates

The last earnings date was Thursday, August 29, 2024.

Earnings Date	Aug 29, 2024
Ex-Dividend Date	n/a

Share Statistics

BioHarvest Sciences has 17.33 million shares outstanding. The number of shares has increased by 8.55% in one year.

Shares Outstanding	17.33M
Shares Change (YoY)	+8.55%
Shares Change (QoQ)	+18.94%
Owned by Insiders (%)	19.29%
Owned by Institutions (%)	n/a
Float	12.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.15
PB Ratio	14.26
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.21
EV / Sales	5.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.97

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of 155.00.

Current Ratio	1.04
Quick Ratio	0.75
Debt / Equity	155.00
Debt / EBITDA	n/a
Debt / FCF	-1.13
Interest Coverage	-1.63

Financial Efficiency

Return on equity (ROE) is -5,955.96% and return on invested capital (ROIC) is -44.89%.

Return on Equity (ROE)	-5,955.96%
Return on Assets (ROA)	-25.83%
Return on Capital (ROIC)	-44.89%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.02
Inventory Turnover	4.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.00% in the last 52 weeks. The beta is 1.48, so BioHarvest Sciences's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	+20.00%
50-Day Moving Average	7.76
200-Day Moving Average	8.16
Relative Strength Index (RSI)	48.12
Average Volume (20 Days)	2,574

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioHarvest Sciences had revenue of CAD 26.18 million and -22.21 million in losses. Loss per share was -1.55.

Revenue	26.18M
Gross Profit	13.47M
Operating Income	-10.62M
Pretax Income	-22.21M
Net Income	-22.21M
EBITDA	-9.87M
EBIT	-10.62M
Loss Per Share	-1.55

Full Income Statement

Balance Sheet

The company has 7.07 million in cash and 14.22 million in debt, giving a net cash position of -7.14 million or -0.41 per share.

Cash & Cash Equivalents	7.07M
Total Debt	14.22M
Net Cash	-7.14M
Net Cash Per Share	-0.41
Equity (Book Value)	9.17M
Book Value Per Share	0.53
Working Capital	433,862

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.93 million and capital expenditures -3.64 million, giving a free cash flow of -12.57 million.

Operating Cash Flow	-8.93M
Capital Expenditures	-3.64M
Free Cash Flow	-12.57M
FCF Per Share	-0.73

Full Cash Flow Statement

Margins

Gross margin is 51.44%, with operating and profit margins of -40.54% and -84.84%.

Gross Margin	51.44%
Operating Margin	-40.54%
Pretax Margin	-84.84%
Profit Margin	-84.84%
EBITDA Margin	-37.71%
EBIT Margin	-40.54%
FCF Margin	-48.02%

Dividends & Yields

BioHarvest Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.55%
Shareholder Yield	-8.55%
Earnings Yield	-20.47%
FCF Yield	-9.61%

Stock Splits

The last stock split was on June 3, 2024. It was a reverse split with a ratio of 0.0285714.

Last Split Date	Jun 3, 2024
Split Type	Reverse
Split Ratio	0.0285714

Scores

BioHarvest Sciences has an Altman Z-Score of -2.6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.6
Piotroski F-Score	n/a